Search

Hutchison China MediTech Ltd ADR

Chiusa

SettoreSettore sanitario

12.82 -2.21

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

12.53

Massimo

13.51

Metriche Chiave

By Trading Economics

Entrata

-8.9M

-8M

Vendite

3.7M

139M

P/E

Media del settore

140.9

56.597

Margine di Profitto

-5.724

Dipendenti

1,790

EBITDA

18M

4M

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

537M

2.4B

Apertura precedente

15.03

Chiusura precedente

12.82

Notizie sul Sentiment di mercato

By Acuity

50%

50%

144 / 339 Classifica in Healthcare

Hutchison China MediTech Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

9 set 2026, 23:51 UTC

News

Toll Brothers Inc. shares are lower in after-market trading, continuing a trend of declining performance amid broader market pressures and rising crude oil prices.

9 set 2026, 23:51 UTC

News

Lakeland Industries reported a fiscal Q2 net loss of $4.9 million and lower-than-expected sales, leading shares to decline in after-market trading.

9 set 2026, 23:51 UTC

News

Limoneira Co reported third-quarter results that missed expectations, with revenues falling to $43.8 million and shares trading lower in after-market hours.

9 set 2026, 23:51 UTC

Social Media
News

Lockheed Martin received $1.08 billion in defense contract modifications from the U.S. Department of Defense, boosting shares modestly higher during after-market hours.

9 set 2026, 23:41 UTC

News

Ovintiv Inc shares are higher in after-market hours following Stifel's Buy rating and $92.00 price target from analyst David Deckelbaum.

9 set 2026, 23:41 UTC

News

Chewy Inc shares fell in after-market trading following analyst downgrades and price target cuts from Jefferies and Evercore. The stock has declined for five consecutive sessions.

9 set 2026, 23:41 UTC

News

America's CAR-MART Inc shares are lower in after-market hours following disappointing Q2 results, with revenue down 57.1% and a non-GAAP loss of $6.65 per share.

9 set 2026, 23:36 UTC

News

DICK'S Sporting Goods is facing a class action lawsuit over alleged false statements regarding its business operations, contributing to a decline in after-market hours.

9 set 2026, 23:31 UTC

Social Media
News

Apple Inc. introduced new AirPods 5 and Apple Watch Series 12, enhancing audio and health features. Shares are trading higher in after-market hours.

9 set 2026, 23:26 UTC

News

Abbott Laboratories received U.S. FDA approval for its TactiFlex Duo ablation catheter. Shares are higher in after-market trading, reflecting a recovery from recent declines.

9 set 2026, 23:21 UTC

News

L3Harris Technologies shares are trading higher in after-market hours, recovering from three consecutive declines despite broader market pressures from rising U.S. Treasury yields.

9 set 2026, 23:21 UTC

News

Verizon shares are higher in after-market hours following a positive investor conference, where executives highlighted strong broadband growth and strategic cost-cutting measures.

9 set 2026, 23:16 UTC

News

Joby Aviation appoints Sergey Novikov as Principal Accounting Officer, effective September 2026. Shares are higher in after-market trading following this leadership change.

9 set 2026, 23:16 UTC

News

Dycom Industries shares are higher in after-market trading ahead of a meeting with KeyBanc on September 16, reflecting investor interest in strategic discussions.

9 set 2026, 23:11 UTC

News

Nasdaq Inc shares advanced modestly in after-market trading following three consecutive lower sessions, amid rising crude oil prices and inflation concerns impacting monetary policy.

9 set 2026, 23:06 UTC

News
Correlated Moves

Intuit Inc. filed an automatic mixed securities shelf, with shares trading lower in after-market hours, reflecting a broader decline and correlation with Adobe Inc.

9 set 2026, 23:06 UTC

News

Boeing Co advances in U.S. Army interceptor competition, shares trading higher in after-market hours. Only two firms have progressed in the selection process.

9 set 2026, 23:06 UTC

Social Media
News

Coca-Cola's CEO outlines a strategy focusing on digital advancements and balanced growth. Shares remain roughly flat in after-market trading since Wednesday's close.

9 set 2026, 23:06 UTC

News

Stifel analyst David Deckelbaum resumed coverage on APA Corp with a Buy rating. Shares are higher in after-market hours, closing at $43.55.

9 set 2026, 23:06 UTC

News

Conagra Brands Inc. shares rose in after-market trading after Slim Jim set a Guinness World Record for the longest meat snack stick at 429 feet.

9 set 2026, 23:06 UTC

News

Simon Property Group priced $800 million in senior notes to repay debt. Shares are trading higher in after-market hours following the announcement.

9 set 2026, 23:06 UTC

News
Correlated Moves

ADP data shows an increase of 12,000 jobs, influencing USD/CZK, which is trading higher. The pair remains within its one-month trading range.

9 set 2026, 23:06 UTC

News

Permian Resources shares rise in after-market hours following a Buy rating from Stifel analyst David Deckelbaum and a target price of $30.00.

9 set 2026, 23:06 UTC

Social Media
News

Meta Platforms Inc shares are lower in after-market hours following the departure of key AI researcher Andrew Tulloch and concerns over tax breaks for data centers.

9 set 2026, 23:06 UTC

News

Beam Therapeutics shares are trading higher in after-market hours following a presentation at Citigroup's Biopharma Summit, highlighting advancements in its pipeline.

9 set 2026, 23:02 UTC

Social Media
News

American Eagle Outfitters shares fell in after-hours trading following a second-quarter earnings report that included a $134.08 million net income and a cautious sales outlook.

9 set 2026, 23:01 UTC

Event
Social Media
News

Cooper Companies reported a net income of $432.8 million but missed revenue expectations, leading to a decline in after-hours trading. Fourth-quarter guidance was lowered.

9 set 2026, 23:01 UTC

News

Wix.com Ltd shares decline in after-market hours amid legal challenges from two class action lawsuits over misleading statements about its AI offerings and costs.

9 set 2026, 23:01 UTC

News

T-Mobile US participated in Citi's TMT Conference, where CFO Peter Osvaldik announced his retirement. Shares are higher in after-market trading.

9 set 2026, 23:01 UTC

Social Media
News

Adobe shares declined in after-market hours amid concerns over OpenAI's advertising policy affecting its product promotion. The stock remains below its 20-day moving average.

Confronto tra pari

Modifica del prezzo

Hutchison China MediTech Ltd ADR Previsione

Consenso sulla valutazione

By TipRanks

Da acquistare moderatamente

3 ratings

2

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

144 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat